Literature DB >> 16166052

Intracranial involvement in Hodgkin's disease.

Canan Akyüz1, Bilgehan Yalcin, I Lale Atahan, Ali Varan, M Tezer Kutluk, Münevver Büyükpamukçu.   

Abstract

The authors report 3 cases of Hodgkin's disease with intracranial involvement. The patients were 4, 12, and 15 years old (male/female=1/2). Initially, they were treated with ABVD or COPP chemotherapies and low-dose involved field radiotherapy. Intracranial recurrences occurred 27, 40, and 42 months after initial diagnosis, respectively. Two patients experienced convulsions and the other complained of diplopia. The metastatic lesions were located supratentorially with CT or MRI. Despite initial response achieved following systemic chemotherapy and external irradiation to cranial lesions, all patients died with disseminated disease. In patients with intracranial involvement of Hodgkin's disease, prolonged disease-free survival may be achieved by combined modality treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166052     DOI: 10.1080/08880010500198863

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  4 in total

Review 1.  Cerebellar involvement in Hodgkin's lymphoma: an atypical site of relapse.

Authors:  Aurora Sanz; Angel Montero; Clara Salas; Enrique Amaya; Gemma Rodríguez; Rosa Magallón; Alejandro de la Torre
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Recurrent Hodgkin's Disease Presenting as a Clinically Isolated Cavernous Sinus Syndrome.

Authors:  Aayesha Jalaluddin Soni; Edward Bernard Lee-Pan
Journal:  Case Rep Neurol Med       Date:  2021-08-07

3.  Classical Hodgkin Lymphoma involving the central nervous system (brain) - an unusual presentation.

Authors:  Sarah Alexandra van Blydenstein; Moosa Patel; Vinitha Philip; Atul Lakha; Sugeshnee Pather; Tracy Westgarth-Taylor; Eddison Thompson; Avinash Kolloori
Journal:  Clin Case Rep       Date:  2014-04-15

Review 4.  Rare central nervous system lymphomas.

Authors:  Furqaan Ahmed Kaji; Nicolás Martinez-Calle; Vishakha Sovani; Christopher Paul Fox
Journal:  Br J Haematol       Date:  2022-03-16       Impact factor: 8.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.